Overview Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients Status: Completed Trial end date: 2013-08-01 Target enrollment: Participant gender: Summary This study is to evaluate the pharmacokinetics and safety of M518101 in male and female plaque psoriasis patients. Phase: Phase 1 Details Lead Sponsor: Maruho North America Inc.